Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

Journal of the American College of Cardiology

Volumn 32, Issue 5, 1998, Pages 1336-1344

  Böger, Rainer H ^a   Bode Böger, Stefanie M ^a   Thiele, Wolfgang ^a   Creutzig, Andreas ^a   Alexander, Klaus ^a   Frölich, Jürgen C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; NITRIC OXIDE; PROSTAGLANDIN E1;

ADULT; AGED; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; FEMALE; HEMODYNAMICS; HUMAN; INTERMITTENT CLAUDICATION; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; WALKING;

AGED; AGED, 80 AND OVER; ALPROSTADIL; ARGININE; ARTERIAL OCCLUSIVE DISEASES; BLOOD FLOW VELOCITY; CHRONIC DISEASE; CYCLIC GMP; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; INTERMITTENT CLAUDICATION; LEG; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; PERIPHERAL VASCULAR DISEASES; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASODILATION; VASODILATOR AGENTS;

EID: 0342991848     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00375-1     Document Type: Article

References (45)

1. Coffman JD. Intermittent claudication: not so benign. Am Heart J 1986;112: 1127-8.
2. Förstermann U, Mügge A, Alheid U, Haverich A, Frölich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988;62:185-90.
3. Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 1995;38:105-28.
4. 1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trial. J Vasc Surg 1997;25:537-44.
5. 1. Vasa 1989;28 Suppl:19-25.
6. Moncada S, Higgs EA. The L-arginine - nitric oxide pathway. N Engl J Med 1993;329:2002-12.
7. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 1991;83:1057-62.
8. Böger RH, Bode-Böger SM, Mügge A, et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995;117:273-84.
9. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991;338:1546-50.
10. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997;95:2068-74.
11. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherosclerotic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992;90:1168-72.
12. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-53.
13. Bode-Böger SM, Böger RH, Alfke H, et al. L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation 1996;93:85-90.
14. European Working Group on Critical Limb Ischemia. Second European Consensus Document on Chronic Critical Limb Ischemia. Circulation 1991;84 Suppl IV:1-26.
15. Heidrich H, Allenberg J, Cachovan M, et al. Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. Vasa 1992;21:339-43.
16. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Circulation 1995;92:614-21.
17. Sorensen KE, Celermajer DS, Spiegelthaler DJ, et al. Non-invasive measurement of human endothelium-dependent arterial responses: accuracy and reproducibility. Br Heart J 1995;74:247-53.
18. Ranke C, Hendrickx P, Roth U, Brassel F, Creutzig A, Alexander K. Color and conventional image-directed Doppler ultrasonography: accuracy and sources of error in quantitative blood flow measurements. J Clin Ultrasound 1992;20:187-93.
19. 15N-labelled analogs. J Chromatogr B 1994;661:185-91.
20. - excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-NAME in rats. Clin Exp Pharmacol Physiol 1996;23:11-5.
21. Bode-Böger SM, Böger RH, Kienke S, Junker W, Frölich JC. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 1996;219:598-603.
22. Lindgärde F, Labs KH, Rößner M. The pentoxifylline experience: exercise testing reconsidered. Vase Med 1996;1:145-54.
23. 15O-water positron emission tomography study. Clin Sci 1997;93:159-65.
24. 1 in peripheral vascular disease. A PET-study of muscular blood flow. Scand J Clin Lab Invest 1998;58:109-17.
25. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-9.
26. Cox DA, Vita JA, Treasure CB, et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation 1989;80:458-65.
27. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 1990;16:349-56.
28. Rector TS, Bank AJ, Mullen KA, et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996;93:2135-41.
29. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm blood pressure as an independent predictor of mortality. Atherosclerosis 1991;87:119-28.
30. Randall MD, Ujiie H, Griffith TM. L-arginine reverses the impairment of nitric oxide-dependent collateral perfusion in dietary-induced hypercholesterolemia in the rabbit. Clin Sci 1994;87:53-9.
31. 1 on collateral vessels in peripheral occlusive vascular disease. Progr Clin Biol Res 1989;301:407-9.
32. Randall MD, Griffith TM. EDRF plays a central role in collateral flow after arterial occlusion in rabbit ear. Am J Physiol 1992;263:H752-60.
33. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. JAMA 1995;274:975-80.
34. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-7.
35. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74.
36. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992;20 Suppl 12:60-2.
37. Böger RH, Bode-Böger SM, Brandes RP, et al. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation 1997;96:1282-90.
38. Huk I, Nanobashvili J, Neumayer J, et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997;96:667-75.
39. Cooke JP, Dzau VJ. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation 1997;96:379-82.
40. Radomski MW, Palmer RMJ, Moncada S. Characterization of the L-arginine: nitric oxide pathway in human platelets. Br J Pharmacol 1987;101: 325-8.
41. Theilmeier G, Chan JR, Zalpour C, et al. Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine. Arterioscler Thromb Vase Biol 1997;17:3557-64.
42. Candipan RC, Wang B, Buitrago P, Tsao PS, Cooke JP. Regression or progression. Dependency on nitric oxide. Arterioscler Thromb Vasc Biol 1996;16:44-50.
43. Harima A, Shimizu H, Takagi H. Analgesic effect of L-arginine in patients with persistent pain. Eur Neuropsychopharmacol 1991;1:529-33.
44. Tiwary CM, Rosenbloom AL, Julius RL. Anaphylactic reaction to arginine infusion (letter). N Engl J Med 1973;288:218.
45. Walter JH, Leonhard V. Inborn errors of the urea cycle. Br J Hosp Med 1987;38:136-83.